Development of a 12-Valent HPV L1 Virus-like Particle Vaccine Using an Enhanced Baculovirus Expression System. [PDF]
Kim JD +10 more
europepmc +1 more source
Integrating Adjuvant HPV Vaccination into Cervical Dysplasia Management After LLETZ/Conization. [PDF]
Anton ET +9 more
europepmc +1 more source
New HPV Vaccines on the Market and Future Trends: A State-of-the-Art Review. [PDF]
Akgör U +5 more
europepmc +1 more source
Anal HPV shedding assessed by self-sampling and multiplex real-time PCR among men who have sex with men in N'Djamena, Chad: a feasibility and acceptability study. [PDF]
Koyalta D +7 more
europepmc +1 more source
Cost-effectiveness of HPV catch-up vaccination program in women aged 13-24 years in a middle income country. [PDF]
Tantitamit T +4 more
europepmc +1 more source
Serious adverse events following human papillomavirus vaccination: A systematic review and meta-analysis of post-marketing evidence. [PDF]
Brown H, Nasreen S.
europepmc +1 more source
Global Perspectives on HPV Vaccination: Achievements, Challenges, and Lessons from the Brazilian Experience. [PDF]
Braga A +11 more
europepmc +1 more source
From bench to bedside: Unveiling the background and benefits of nanovaccines tested in clinics. [PDF]
Egorova VS +12 more
europepmc +1 more source
Human Papillomavirus Genotype Landscape Across Cervical Cytology Grades and Impact of HIV Among Women of Eastern Cape Province, South Africa. [PDF]
Kondlo S +3 more
europepmc +1 more source
Clinical research progress and challenges of vaccine for human papillomavirus-associated cancers. [PDF]
Xue L, Li X, Guo X, Xing H, Liu C.
europepmc +1 more source

